CSIMarket
 
Charles River Laboratories International inc   (CRL)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 
Price: $262.1300 $3.16 1.220%
Day's High: $266 Week Perf: -0.75 %
Day's Low: $ 258.88 30 Day Perf: 6.82 %
Volume (M): 380 52 Wk High: $ 275.00
Volume (M$): $ 99,557 52 Wk Avg: $207.30
Open: $260.91 52 Wk Low: $161.65



 Market Capitalization (Millions $) 13,494
 Shares Outstanding (Millions) 51
 Employees 20,000
 Revenues (TTM) (Millions $) 4,129
 Net Income (TTM) (Millions $) 480
 Cash Flow (TTM) (Millions $) 43
 Capital Exp. (TTM) (Millions $) 319

Charles River Laboratories International Inc
Charles River Laboratories International, Inc. is a leading provider of research and preclinical services to help biotechnology, pharmaceutical, and other life sciences companies bring their products to market. The company is headquartered in Wilmington, Massachusetts and has more than 100 facilities around the world. Charles River Laboratories operates in three main business segments: Research Models and Services, Discovery and Safety Assessment, and Manufacturing Support.

The Research Models and Services segment provides laboratory animal models and associated services to help researchers understand disease and test new drugs. The company offers a range of products including mice, rats, guinea pigs, hamsters, and nonhuman primates. Additionally, Charles River Laboratories provides model creation and breeding, barrier and containment facilities, and research support services.

The Discovery and Safety Assessment segment offers preclinical research and safety assessment services to pharmaceutical and biotechnology companies. The company conducts studies to evaluate the safety and efficacy of potential new drugs, including toxicology studies and safety pharmacology studies. Charles River Laboratories also provides high-throughput screening services, in vitro ADME/DMPK services, and in vivo pharmacology and efficacy services.

The Manufacturing Support segment provides biologics testing services and support through end-to-end solutions to help customers get their products to market quickly and efficiently. The company offers a wide range of services including cGMP manufacturing support, viral clearance studies, and regulatory support services.

Through a combination of its diverse service offerings and global presence, Charles River Laboratories has become a trusted partner for many large and small biotechnology and pharmaceutical companies. The company is committed to making significant contributions to the development of new drugs and therapies that will help save and improve lives.


   Company Address: 251 Ballardvale Street Wilmington 1887 MA
   Company Phone Number: 222-6000   Stock Exchange / Ticker: NYSE CRL
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Product Service News

Charles River Laboratories and Navega Therapeutics Unite Forces for Advanced Gene Therapy Manufacturing

Published Thu, Mar 14 2024 12:00 PM UTC

Charles River Laboratories and Navega Therapeutics Enter Collaboration for Gene Therapy ManufacturingWILMINGTON, Mass. - Charles River Laboratories International, Inc. and Navega Therapeutics, Inc. have announced a comprehensive gene therapy manufacturing collaboration. As part of Charles River's Cell and Gene Therapy (CGT) Accelerator Program (CAP), Navega will gain access ...

Product Service News

Charles River and Wheeler Bio Join Forces to Revolutionize Biotech Manufacturing and Testing Capabilities

Published Wed, Feb 21 2024 1:00 PM UTC

Charles River Laboratories and Wheeler Bio Join Forces to Enhance Biotech Manufacturing CapabilitiesWILMINGTON, Mass. & OKLAHOMA CITY ?? Charles River Laboratories International, Inc., a leading contract research organization, has announced a strategic collaboration with Wheeler Bio, Inc., an antibody contract development and manufacturing organization (CDMO). This partnersh...

Product Service News

Charles River Expands Stem Cell Portfolio through Collaboration with Pluristyx and Achieves Manufacturing Milestone in Cell Therapy

Published Tue, Feb 20 2024 1:08 PM UTC

In a recent announcement, Charles River Laboratories International, Inc. has entered into a collaboration agreement with Pluristyx Inc., a renowned provider of tools, technologies, and services for cell therapy development. This collaboration expands Charles River's access to a wide range of highly characterized and unique stem cell lines, including embryonic stem cells (ES)...

Charles River Laboratories International Inc

Charles River Laboratories International Inc. Faces Decreased Income and Growing Concerns Over Future Growth Potential

The financial results of Charles River Laboratories International Inc. for the most recent fiscal period show a mixed picture. While earnings per share decreased slightly compared to the previous year, there was a significant increase in Income per Share from the preceding quarter. The revenue has decreased both year-over-year and sequentially, which could raise concerns about the company's growth potential.
However, it is important to note that the company's net margin improved, indicating that they might be managing their expenses more effectively. The increase in inventories and supplies, as well as the decline in accounts receivable, could impact the company's cash flow and liquidity in the short term.

Product Service News

Revolutionizing Bacterial Endotoxin Testing: Charles River Laboratories Launches First Rapid Animal-Free Solution

Published Mon, Jan 29 2024 1:00 PM UTC

Charles River Laboratories Introduces Groundbreaking Animal-Free Bacterial Endotoxin TestCharles River Laboratories International, Inc. has made a significant breakthrough in the field of bacterial endotoxin testing (BET) by launching the Endosafe Trillium rCR cartridge offering. This new innovation combines the company's flagship Endosafe cartridge technology with their rec...






 

Charles River Laboratories International Inc's Segments
 
 
• View Complete Report
  Company Estimates  
  Revenue Outlook
Charles River Laboratories International Inc does not provide revenue guidance.

Earnings Outlook
Charles River Laboratories International inc does not provide earnings estimates.

 
Geographic Revenue Dispersion




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com